Neuraxis Inc (NRXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,627 | -13,034 | -4,409 | -2,173 | -4,780 |
| Depreciation Amortization | 4,922 | 4,912 | 3,571 | 2,673 | 136 |
| Accounts receivable | 76 | 36 | -67 | -185 | N/A |
| Accounts payable and accrued liabilities | -388 | -1,026 | 846 | 469 | N/A |
| Other Working Capital | -666 | -1,445 | 1,088 | 427 | 1,270 |
| Other Operating Activity | 3,988 | 6,493 | -2,278 | -1,832 | 1,076 |
| Operating Cash Flow | $-6,694 | $-4,064 | $-1,248 | $-623 | $-2,298 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31 | -15 | -12 | -8 | -1 |
| Purchase Sale Intangibles | -41 | -41 | -1 | N/A | N/A |
| Other Investing Activity | -41 | -41 | -1 | 0 | -60 |
| Investing Cash Flow | $-72 | $-56 | $-13 | $-8 | $-61 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,620 | 5,068 | 3,988 | 3,197 | N/A |
| Debt Repayment | -3,534 | -3,488 | -2,725 | -2,695 | N/A |
| Common Stock Issued | 5,057 | 5,465 | N/A | 0 | N/A |
| Other Financing Activity | -552 | -2,417 | -204 | -79 | 2,292 |
| Financing Cash Flow | $6,591 | $4,628 | $1,059 | $422 | $2,292 |
| Beginning Cash Position | 254 | 254 | 254 | 254 | 321 |
| End Cash Position | 79 | 761 | 51 | 46 | 254 |
| Net Cash Flow | $-175 | $508 | $-202 | $-208 | $-67 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,694 | -4,064 | -1,248 | -623 | -2,298 |
| Capital Expenditure | -31 | -15 | -12 | -8 | N/A |
| Free Cash Flow | -6,725 | -4,079 | -1,260 | -631 | -2,298 |